HBeAg clearance in chronic Hepatitis B: is it predictable?
Introduction: Prediction of HBeAg loss is crucial for understanding the prognosis of chronic hepatitis B (CHB) and determining when to discontinue treatment. We aimed to identify factors predicting HBeAg clearance in patients undergoing antiviral treatment for HBeAg-positive CHB Methodology: This...
Saved in:
Main Authors: | Tuba İlgar, Aybegüm Özşahin, Sudem Mahmutoğlu Çolak, İlknur Esen Yıldız, Uğur Kostakoğlu, Ayşe Ertürk |
---|---|
Format: | Article |
Language: | English |
Published: |
The Journal of Infection in Developing Countries
2025-06-01
|
Series: | Journal of Infection in Developing Countries |
Subjects: | |
Online Access: | https://www.jidc.org/index.php/journal/article/view/20784 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence and clinical significance of HBeAg-positive chronic hepatitis B patients with and without anti-HBe antibody
by: Ruifei Xue, et al.
Published: (2025-12-01) -
Comparative Efficacy of Etiotropic Therapy of Patients with HBeAg-Positive Chronic Hepatitis B (by the Data of the International Comparative Placebo-Controlled Study)
by: V. V. Stelmakh, et al.
Published: (2020-05-01) -
High immunocompetence in chronic hepatitis patients with normal alanine transaminase levels and and negative hepatitis B e‐antigen for the progression of liver fibrosis
by: Bianqiao Cheng, et al.
Published: (2024-01-01) -
Performance of APRI and FIB-4 Scores Compared to FibroScan: A Cross-Sectional Study in a Black Sub-Saharan African Population
by: Nsumbu JB, et al.
Published: (2025-07-01) -
Clinical Characteristics of Alcohol-Related Liver Disease in Albanian Patients: A Cross-Sectional Study
by: Dorina Osmanaj, et al.
Published: (2025-04-01)